Skip to Main Content

Advertisement

Umbrella Alt Text
Cart
header search
Search
Skip Nav Destination

Issue Archive

Volume 128, Issue 21
November 24 2016
Issue Cover

Table of Contents

BLOOD FLASHBACK

Burgess AW, Wilson EMA, Metcalf D. Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells. Blood. 1977;49(4):573-583.
View Articletitled, Burgess AW, Wilson EMA, Metcalf D. Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells. <em>Blood</em>. 1977;49(4):<span class="related-article">573-583</span>.

INSIDE BLOOD COMMENTARIES

INSIDE BLOOD COMMENTARY
Is the lymphoma better? Not easy to determine
Joseph M. Connors
View Articletitled, Is the lymphoma better? Not easy to determine
INSIDE BLOOD COMMENTARY
Novel antivirals for HCV-associated lymphomas
Diego Villa
View Articletitled, Novel antivirals for HCV-associated lymphomas
INSIDE BLOOD COMMENTARY
Pericytes: new EPO-producing cells in the brain
Peng Ji
View Articletitled, Pericytes: new EPO-producing cells in the brain
INSIDE BLOOD COMMENTARY
Glycans of plasma ADAMTS13
Karen Vanhoorelbeke
View Articletitled, Glycans of plasma ADAMTS13
INSIDE BLOOD COMMENTARY
Sickle cell disease: the price of cure
Irene Roberts,Josu de la Fuente
View Articletitled, Sickle cell disease: the price of cure

PERSPECTIVES

Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy
Clinical Trials & Observations
Bruce D. Cheson,Stephen Ansell,Larry Schwartz,Leo I. Gordon,Ranjana Advani,Heather A. Jacene,Axel Hoos,Sally F. Barrington,Philippe Armand
View Articletitled, Refinement of the Lugano Classification lymphoma response criteria in the era of immunomodulatory therapy

REVIEW ARTICLE

Discussing and managing hematologic germ line variants
Clinical Trials & Observations
Wendy Kohlmann,Joshua D. Schiffman
View Articletitled, Discussing and managing hematologic germ line variants
Pure red cell aplasia
Robert T. Means, Jr
View Articletitled, Pure red cell aplasia

CLINICAL TRIALS AND OBSERVATIONS

Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103
Clinical Trials & Observations
Chaitra S. Ujjani,Sin-Ho Jung,Brandelyn Pitcher,Peter Martin,Steven I. Park,Kristie A. Blum,Sonali M. Smith,Myron Czuczman,Matthew S. Davids,Ellis Levine,Lionel D. Lewis,Scott E. Smith,Nancy L. Bartlett,John P. Leonard,Bruce D. Cheson
View Articletitled, Phase 1 trial of rituximab, lenalidomide, and ibrutinib in previously untreated follicular lymphoma: Alliance A051103

LYMPHOID NEOPLASIA

HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma
Caron Jacobson,Nadja Kopp,Jacob V. Layer,Robert A. Redd,Sebastian Tschuri,Sarah Haebe,Diederik van Bodegom,Liat Bird,Amanda L. Christie,Alexandra Christodoulou,Amy Saur,Trevor Tivey,Stefanie Zapf,Deepak Bararia,Ursula Zimber-Strobl,Scott J. Rodig,Oliver Weigert,David M. Weinstock
View Articletitled, HSP90 inhibition overcomes ibrutinib resistance in mantle cell lymphoma
Supplemental data
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection
Clinical Trials & Observations
Luca Arcaini,Caroline Besson,Marco Frigeni,Hélène Fontaine,Maria Goldaniga,Milvia Casato,Marcella Visentini,Harrys A. Torres,Veronique Loustaud-Ratti,Jan Peveling-Oberhag,Paolo Fabris,Roberto Rossotti,Francesco Zaja,Luigi Rigacci,Sara Rattotti,Raffaele Bruno,Michele Merli,Céline Dorival,Laurent Alric,Arnaud Jaccard,Stanislas Pol,Fabrice Carrat,Virginia Valeria Ferretti,Carlo Visco,Olivier Hermine
View Articletitled, Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection
Supplemental data

MYELOID NEOPLASIA

Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis
Clinical Trials & Observations Brief Report
Rikhia Chakraborty,Thomas M. Burke,Oliver A. Hampton,Daniel J. Zinn,Karen Phaik Har Lim,Harshal Abhyankar,Brooks Scull,Vijetha Kumar,Nipun Kakkar,David A. Wheeler,Angshumoy Roy,Poulikos I. Poulikakos,Miriam Merad,Kenneth L. McClain,D. Williams Parsons,Carl E. Allen
View Articletitled, Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis
Supplemental data

PLATELETS AND THROMBOPOIESIS

Respective contributions of single and compound granule fusion to secretion by activated platelets
Anita Eckly,Jean-Yves Rinckel,Fabienne Proamer,Neslihan Ulas,Smita Joshi,Sidney W. Whiteheart,Christian Gachet
View Articletitled, Respective contributions of single and compound granule fusion to secretion by activated platelets
Supplemental data

RED CELLS, IRON, AND ERYTHROPOIESIS

Prolyl-4-hydroxylase 2 and 3 coregulate murine erythropoietin in brain pericytes
Andres A. Urrutia,Aqeela Afzal,Jacob Nelson,Olena Davidoff,Kenneth W. Gross,Volker H. Haase
View Articletitled, Prolyl-4-hydroxylase 2 and 3 coregulate murine erythropoietin in brain pericytes
Supplemental data

THROMBOSIS AND HEMOSTASIS

Identification of glycans on plasma-derived ADAMTS13
e-blood
Fabian C. Verbij,Eva Stokhuijzen,Paul H. P. Kaijen,Floris van Alphen,Alexander B. Meijer,Jan Voorberg
View Articletitled, Identification of glycans on plasma-derived ADAMTS13
Supplemental data

TRANSPLANTATION

A trial of unrelated donor marrow transplantation for children with severe sickle cell disease
Clinical Trials & Observations
Shalini Shenoy,Mary Eapen,Julie A. Panepinto,Brent R. Logan,Juan Wu,Allistair Abraham,Joel Brochstein,Sonali Chaudhury,Kamar Godder,Ann E. Haight,Kimberly A. Kasow,Kathryn Leung,Martin Andreansky,Monica Bhatia,Jignesh Dalal,Hilary Haines,Jennifer Jaroscak,Hillard M. Lazarus,John E. Levine,Lakshmanan Krishnamurti,David Margolis,Gail C. Megason,Lolie C. Yu,Michael A. Pulsipher,Iris Gersten,Nancy DiFronzo,Mary M. Horowitz,Mark C. Walters,Naynesh Kamani
View Articletitled, A trial of unrelated donor marrow transplantation for children with severe sickle cell disease
Supplemental data
Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cells
Scott N. Furlan,Benjamin Watkins,Victor Tkachev,Sarah Cooley,Angela Panoskaltsis-Mortari,Kayla Betz,Melanie Brown,Daniel J. Hunt,John B. Schell,Katie Zeleski,Alison Yu,Cynthia R. Giver,Edmund K. Waller,Jeffrey S. Miller,Bruce R. Blazar,Leslie S. Kean
View Articletitled, Systems analysis uncovers inflammatory Th/Tc17-driven modules during acute GVHD in monkey and human T cells
Supplemental data

LETTERS TO BLOOD

Current growth patterns in children and adolescents with thalassemia major
Raffaella Origa,Fabrice Danjou,Valeria Orecchia,Antonietta Zappu,Carlo Dessì,Maria Loreta Foschini,Giovan Battista Leoni,Paolo Moi,Maddalena Morittu,Anna Demurtas,Sandro Loche
View Articletitled, Current growth patterns in children and adolescents with thalassemia major
Supplemental data

BLOOD WORK

Pseudo Chediak-Higashi anomaly in acute monoblastic leukemia
Yahya Daneshbod,L. Jeffrey Medeiros
View Articletitled, Pseudo Chediak-Higashi anomaly in acute monoblastic leukemia
Characteristic peripheral blood smear findings in disorders of cobalamin metabolism
Hojun Li,Colin Sieff
View Articletitled, Characteristic peripheral blood smear findings in disorders of cobalamin metabolism

ERRATA

Gill S, Tasian SK, Ruella M, et al. Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cells. Blood. 2014;123(15):2343-2354.
View Articletitled, Gill S, Tasian SK, Ruella M, et al. Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor–modified T cells. <em>Blood</em>. 2014;123(15):2343-2354.
Morillo-Gutierrez B, Beier R, Rao K, et al. Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience. Blood. 2016;128(3):440-448.
View Articletitled, Morillo-Gutierrez B, Beier R, Rao K, et al. Treosulfan-based conditioning for allogeneic HSCT in children with chronic granulomatous disease: a multicenter experience. <em>Blood.</em> 2016;128(3):440-448.
All Issues

Advertisement

Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy
NGS-based stratification refines the risk stratification in T-ALL and identifies a Very High-Risk subgroup of patients
Foxo1 is an iron-responsive transcriptional factor regulating systemic iron homeostasis
How I Treat Low-risk Polycythemia Vera Patients who Require Cytoreduction
How I manage major hemorrhage

Advertisement

Advertisement

  • American Society of Hematology
  • 2021 L Street NW, Suite 900
  • Washington, DC 20036
  • TEL +1 202-776-0544
  • FAX +1 202-776-0545

ASH Publications

American Society of Hematology

Copyright 2024 by American Society of Hematology
 
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal

Advertisement